Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOX index range for gag reflex inhibition during painless gastrointestinal endoscopy
ChiCTR2100053838Phase 4Not yet recruiting
- Sponsor
- Southern Medical University Shenzhen Hospital
- Start
- Jan 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol, sufentanil and esketamine (4 arms), sponsored by Southern Medical University Shenzhen Hospital. Primary endpoint: Incidence of adverse reactions during gastroenteroscopy. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
propofolsufentanilesketamine
Beyond the preview
Go deeper on ChiCTR2100053838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053838.